The Wegovy pill is a once-daily tablet that contains the active ingredient semaglutide, which is the same active ingredients as the Wegovy injection. Semaglutide is a GLP-1 receptor agonist that mimics the action of the naturally occurring GLP-1 hormone released by your body after eating. This hormone plays an important role in regulating appetite and supporting healthy blood sugar levels. By activating GLP-1 receptors, the Wegovy pill helps your body better manage hunger signals, making it easier to consume fewer calories without feeling deprived.
The Wegovy pill supports weight loss through several complementary mechanisms. It reduces appetite and food cravings, helping you feel satisfied with smaller portions, while also slowing gastric emptying so food remains in the stomach for longer, promoting a prolonged feeling of fullness after meals.
Semaglutide also helps regulate blood sugar by increasing insulin release when blood glucose levels are elevated, reducing blood sugar spikes that can contribute to hunger and cravings. Together, these effects can support sustainable weight management when combined with a balanced diet and regular physical activity.
At Bodyline, the Wegovy pill is prescribed through a clinician-led assessment process designed to ensure the treatment is suitable and safe for you. Before starting your programme, our experienced healthcare team will review your health history, weight management goals, and individual circumstances to determine whether the Wegovy pill is an appropriate treatment option as part of a Bodyline supported weight loss programme.
If the Wegovy pill is suitable, you will start a personalised treatment plan with ongoing clinical support throughout your journey. Our clinician-led programme prioritises patient safety, with comprehensive assessments before treatment, regular reviews during your programme, and personalised advice to help you use your medication effectively while minimising the risk of side effects. You can feel confident knowing you're supported by experienced healthcare professionals every step of the way.
*Novo Nordisk OASIS 4 phase 3 clinical programme for Oral Semaglutide 2022 - 2024
Patient success stories
I’ve put so many people onto Bodyline. One friend of mine, another mum from school started to use it and she’s already lost 2 stone! It works so quickly.
I had just always struggled, and I was sick of the way that I was. The dieting never went well. But then I saw how well my mum had done, and I was like you know what, I'm going to try Bodyline.
Talk to our clinical team for no-obligation advice, in clinic or by video.
Contact us today
Find out more about how we can treat and support you to improve your health and wellbeing.
No-obligation advice from our CQC-regulated team, in clinic or by video.
